Hepatic Local Disposition of a Drug with High Protein Binding and High Hepatic Clearance Using BOF-4272 as a Model Drug
スポンサーリンク
概要
- 論文の詳細を見る
The local disposition of a drug, which is efficiently eliminated by the liver in spite of very high binding with serum albumin, was investigated using BOF-4272 as a model drug in the hepatic perfusion system. Bovine serum albumin (BSA) labeled with Evans Blue was used as the marker of hepatic blood space. The perfusion experiments were carried out at 37℃ and at 4℃ to evaluate the local disposition in active and inactive livers, respectively. The perfusates included 0,0.25,0.5,1.0 and 4.0% of BSA in the injection of BOF-4272,and 0 and 1.0% of BSA in the injection of Evans Blue. After an instantaneous injection of BOF-4272 or Evans Blue (labeling reagent of BSA), the outflow time profile from the liver was analyzed by curve-fitting based on two-compartment dispersion model. All estimated parameters of BSA were almost the same between 37℃ and 4℃, which showed that the blood space in the liver was unaffected by perfusate temperature. The recovery ratio (F_H) and the mean transit time (t^^-_H) of BSA were 100% and about 0.1 min, respectively, both with BSA (1.0%) and without BSA in the perfusate. F_H of BOF-4272 increased from 20% to 50% with an increase in the perfusate BSA at 37℃, whereas F_H was almost constant (90%) regardless of BSA concentration at 4℃. t^^-_H of BOF-4272 was almost 0.1 min regardless of BSA concentration at 37℃, whereas t^^-_H decreased from 0.29 min to 0.17 min at 4℃ with an increase in the perfusate BSA. A large elimination (10%) of BOF-4272 was noticed even at 4℃ in the presence of perfusate BSA, which demonstrates that the passive transfer of BOF-4272 from BSA to the hepatic tissues is considerably rapid. This efficient transfer is responsible for the large hepatic clearance of BOF-4272 with very high binding with BSA.
- 公益社団法人日本薬学会の論文
- 1996-09-15
著者
-
NAITO Shinsaku
Research and Development Center, Otsuka Pharmaceutical Factory, Inc.
-
Nishimura M
Research And Development Center Otsuka Pharmaceutical Factory Inc.
-
Nishimura Masuhiro
Laboratory Of Drug Metabolism Research Naruto Research Institute Otsuka Pharmaceutical Factory Inc.
-
Nishimura Masuhiro
Department Of Drug Metabolism Division Of Pharmacology Drug Safety And Metabolism Otsuka Pharmaceuti
-
Yamada Kazushi
Department Of Pharmacy:department Of Internal Medicine Kyoto University Hospital Faculty Of Medicine
-
YAMAOKA Kiyoshi
Faculty of Pharmaceutical Sciences, Kyoto University
-
NAITO Shinsaku
Laboratory of Drug Metabolism Research, Naruto Research Institute, Otsuka Pharmaceutical Factory, In
-
NAKAGAWA Terumichi
Faculty of Pharmaceutical Sciences, Kyoto University
-
Naito S
Otsuka Pharmaceutical Factory Inc. Tokushima Jpn
-
Naito Shinsaku
Laboratory Of Drug Metabolism Research Naruto Research Institute Otsuka Pharmaceutical Factory Inc.
-
Nakagawa T
Graduate School Of Pharmaceutical Sciences Kyoto University
-
Yamaoka K
Moa Health Science Foundation Life Science Institute
-
Nakagawa Terumichi
Faculty Of Pharmaceutical Science Kyoto University
-
Yamaoka Kiyoshi
Faculty Of Pharmaceutical Science Kyoto University
関連論文
- Laser Ablation of Silk Protein (Fibroin) Films
- Pharmacological assessment of ARTCEREB_【○!R】 irrigation and perfusion solution for cerebrospinal surgery using primary cultures of rat brain cells
- Comparative analysis of ATP-binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma
- Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver
- Perfusion fluids used in neurosurgery affect cerebrospinal fluid and surrounding brain parenchyma in the rat ventriculocisternal perfusion model
- Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes
- Influence of Albumin on Enantioselective Local Disposition of BOF-4272,a Xanthine Oxidase Inhibitor with Chiral Sulfoxide, in Rat Liver
- Hepatic Local Disposition of a Drug with High Protein Binding and High Hepatic Clearance Using BOF-4272 as a Model Drug
- カニクイザルにおける薬物代謝酵素およびトランスポーターmRNAの組織発現プロファイル
- ヒト組織におけるトランスポーター-SLC35ファミリーのmRNA発現プロファイル